# An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

> **NCT01009905** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 22960 (actual)

## Conditions studied

- Growth Hormone Disorder
- Pituitary Dwarfism
- Hypopituitarism

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT01009905
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06-24
- **Primary completion:** 2016-09-30
- **Final completion:** 2016-09-30
- **Target enrollment:** 22960 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01009905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01009905, "An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01009905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*